TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 1 | 1 | 8 | 2 | 5 | -4 | -3 | -21 | -19 | -7 |
P | %wins | 63 | 63 | 50 | 50 | 13 | 25 | 44 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/31/16 16:33 | 8/20/15 | EPZM | Epizyme, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ho Peter Tai-Ching | MA | O | Chief De | P.a | 33 | 16.51 | 4 | 2 | 91 | 4 | D | -50 | -41 | -12 | -32 | 13 | 21 | 5 | 7 | -2 | 9 | -9 | -18 | -18 | 45 |
3/2/16 17:14 | 2/29/16 | EPZM | Epizyme, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ho Peter Tai-Ching | MA | O | Chief De | P | 5 | 7.47 | 4 | 1 | 13 | 5 | D | -69 | -62 | -54 | -44 | -4 | -1 | -3 | 2 | 1 | -1 | 28 | 17 | -22 | 48 |
12/10/15 17:15 | 12/9/15 | EPZM | Epizyme, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ho Peter Tai-Ching | MA | O | Chief De | P | 15 | 14.69 | 5 | 1 | 27 | 5 | D | -35 | -33 | -28 | -32 | 6 | -3 | -13 | 0 | -3 | 15 | -33 | -33 | -21 | -29 |
9/2/15 15:30 | 8/31/15 | EPZM | Epizyme, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ho Peter Tai-Ching | MA | O | Chief De | P | 9 | 17.00 | 8 | 1 | 17 | 4 | D | -29 | -41 | -18 | 2 | -11 | 8 | 23 | 12 | 5 | 3 | -35 | -22 | -51 | -63 |
8/24/15 17:38 | 8/20/15 | EPZM | Epizyme, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ho Peter Tai-Ching | MA | O | Chief De | P | 33 | 16.51 | 7 | 2 | 200 | 3 | D | -43 | -51 | -32 | -17 | -34 | -26 | -13 | -9 | -3 | 16 | 13 | -19 | -54 | -59 |
5/6/15 18:03 | 5/5/15 | EPZM | Epizyme, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ho Peter Tai-Ching | MA | O | Chief De | P | 13 | 16.36 | 5 | 1 | 400 | 1 | I | -26 | -39 | -11 | -20 | -13 | -20 | -1 | 5 | 8 | 16 | 35 | -7 | -43 | |
12/18/14 18:34 | 12/16/14 | EPZM | Epizyme, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ho Peter Tai-Ching | MA | O | Chief De | P | 7 | 17.63 | 8 | 0 | 200 | 1 | I | -14 | -37 | -34 | -32 | -20 | -14 | -2 | 9 | -4 | 2 | 9 | 13 | -15 | |
12/4/14 18:17 | 12/2/14 | EPZM | Epizyme, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ho Peter Tai-Ching | MA | O | Chief De | P | 21 | 21.17 | 10 | 1 | 1 | M | -1 | -7 | -27 | -21 | -10 | -4 | -6 | 3 | -4 | -10 | 7 | -10 | -35 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |